Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

P&G Wins Clairol Bid Without Swapping OTCs

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Procter & Gamble appears committed to strengthening its OTC drug portfolio in the wake of the firm's successful bid for the Clairol hair care business.

You may also be interested in...



P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January

Procter & Gamble's ThermaCare disposable pain-relief heat wraps will begin appearing beside oral analgesics nationwide in January.

P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January

Procter & Gamble's ThermaCare disposable pain-relief heat wraps will begin appearing beside oral analgesics nationwide in January.

P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January

Procter & Gamble's ThermaCare disposable pain-relief heat wraps will begin appearing beside oral analgesics nationwide in January.

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

See All
UsernamePublicRestriction

Register

PS092599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By